Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNew Anti-Rejection Drug Saves Money, Lives
Ivanhoe, 10/16/09
A newer, less expensive drug used to prevent organ rejection has been shown to be equally as effective and safe as its more expensive counterpart. In a study researchers compared the effectiveness of two drugs used to reduce the chances of rejection in kidney and pancreas transplants: alemtuzumab, a new drug that costs about $1,000 per treatment, and rabbit antithymocyte globulin, which costs about four times as much. Both drugs are used in short–term treatment to rapidly lower the immune system and thus prevent organ rejection.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA approves new seasonal flu vaccine
CNN Health, 11/30/09
Study shows flavanol antioxidant content of US chocolate and cocoa-containing products
EurekAlert, 11/25/09
Medical pay for performance programs help improve care, but not always, study finds
ScienceDaily, 11/25/09
Sponsor
Article Search
Sponsor